Literature DB >> 15498636

Factors influencing outcome in gastric cancer involving muscularis and subserosal layer.

G Fotia1, D Marrelli, A De Stefano, E Pinto, F Roviello.   

Abstract

AIMS: The prognostic factors for advanced gastric carcinoma without serosal invasion (pT2 AGC) are not clear. In terms of prognosis, pT2 AGC is considered intermediate between early gastric cancer (EGC) and gastric carcinoma with serosal invasion.
METHODS: From January 1985 to December 2000, 182 patients with pT2 AGC underwent curative gastric resection in our Department. Prognostic factors were evaluated by univariate and multivariate analyses.
RESULTS: Univariate analysis demonstrated that gender, tumour location, lymph node involvement, Borrmann type, number of lymph nodes involved, venous infiltration and extent of lymphadenectomy were significantly related to the prognosis. Multivariate analysis revealed that extent of lymph node metastasis (N1 vs N0 relative risk (RR) of recurrences=3.96, p<0.05; N2 vs N0 RR=6.55, p<0.05), and extent of lymphadenectomy (D1 vs D2 RR=3.2, p<0.01) were independent prognostic factors. In a subset of patients in which venous infiltration was analysed, this factor was also significant (RR=3.9, p<0.05).
CONCLUSIONS: Our study shows that lymph node involvement and venous infiltration are important prognostic factors for pT2 AGC and, as such, adjuvant chemotherapy could be useful in this group of patients. An extensive lymph node dissection, minimum D2, should always be performed in order to reduce the risk of recurrence.

Entities:  

Mesh:

Year:  2004        PMID: 15498636     DOI: 10.1016/j.ejso.2004.07.004

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  4 in total

1.  Is subdivision of pT2 tumors superior to lymph node metastasis for predicting survival of patients with gastric cancer? Review of 224 patients from four centers.

Authors:  Ahmet Bilici; Faysal Dane; Mesut Seker; Bala Basak Oven Ustaalioglu; Mehmet Aliustaoglu; Suleyman Temiz; Cem Gezen; Dilek Yavuzer; Gorkem Aksu; Alpaslan Mayadagli; Mahmut Gumus; Kazim Uygun; Nazim Serdar Turhal
Journal:  Dig Dis Sci       Date:  2011-06-10       Impact factor: 3.199

2.  A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer.

Authors:  Michiya Kobayashi; Akira Tsuburaya; Naoki Nagata; Yumi Miyashita; Koji Oba; Junichi Sakamoto
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

3.  Sixth and seventh tumor-node-metastasis staging system compared in gastric cancer patients.

Authors:  Tommaso Zurleni; Elson Gjoni; Andrea Ballabio; Roberto Casieri; Paola Ceriani; Luca Marzoli; Francesco Zurleni
Journal:  World J Gastrointest Surg       Date:  2013-11-27

4.  Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients.

Authors:  M Scartozzi; E Galizia; L Verdecchia; R Berardi; F Graziano; V Catalano; P Giordani; D Mari; R R Silva; C Marmorale; C Zingaretti; S Cascinu
Journal:  Br J Cancer       Date:  2006-08-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.